Progentos Therapeutics
Regenerating myelin to restore function in multiple sclerosis
Progentos Therapeutics was founded in 2024, is headquartered in Cambridge, United States, lists 1–10 employees, and has $65.0M in recorded funding across 1 round.
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- progentos.com
- Total Funding
- $65.0M
- Last Round
- $65.0M Series AMay 2024
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 5 investors for this company. The full record is or through the API.
About
Progentos Therapeutics is a Cambridge, Massachusetts-based biotechnology company developing first-in-class small molecule therapeutics to induce remyelination in patients with multiple sclerosis (MS) and other demyelinating diseases. The company's approach targets oligodendrocyte progenitor cells to activate the brain's natural repair mechanisms, regenerating the myelin sheath lost to MS — a mechanism distinct from existing immunomodulatory therapies that only slow disease progression without repairing existing damage. Founded in 2024 by co-founders Chris Loose and Sanjay Magavi and backed by a $65M Series A led by Forbion, Progentos aims to develop the first potentially restorative therapy for MS patients. The company has operations in both Watertown, Massachusetts and Naarden, The Netherlands.
Summary
Progentos Therapeutics is a Biotech company based in Cambridge, United States, founded in 2024. It lists 1–10 employees. It has raised $65.0M in total across 1 round, most recently a $65.0M Series A round in May 2024. Investors include Forbion Capital Partners, Alta Partners and Mission BioCapital.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2024
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/progentos-therapeutics"><img src="https://indexed.vc/api/badge/company/progentos-therapeutics" alt="Progentos Therapeutics on Indexed.vc" width="260" height="76" /></a>